Study to Assess the Prophylactic Efficacy and Safety of Sebaloxavir Marboxil Tablets/Oral Suspension for Influenza Prevention in Household Contacts Aged ≥2 Years.
Clinical trial NCT07730346 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07730346
- Sponsor
- Nanjing Zenshine Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-07
- Primary completion
- 2027-12-31
- Enrollment
- 858
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.